Showing 7441-7450 of 19323 results for "".
APOL1 Screening and Early Detection: Patient and Clinician Perspectives
https://reachmd.com/programs/kdigo-conversations-nephrology/apol1-screening-and-early-detection-patient-and-clinician-perspectives/35712/APOL1 Screening and Early Detection: Patient and Clinician PerspectivesComplement Mediated Kidney Disease Series - A Patient and Caregiver Perspective
https://reachmd.com/programs/cme/complement-mediated-kidney-disease-series-a-patient-and-caregiver-perspective/35709/Complement Mediated Kidney Disease Series - A Patient and Caregiver PerspectiveSymptom Control in gMG: Comparing Ravulizumab and Efgartigimod
https://reachmd.com/programs/neurofrontiers/symptom-control-in-gmg-comparing-ravulizumab-and-efgartigimod/35755/Drawing from the CHAMPION and ADAPT trials, a recent analysis compared symptom control in generalized myasthenia gravis (gMG) patients treated with ravulizumab or efgartigimod. While both biologics demonstrated efficacy, the study found that ravulizumab offered more sustained symptom stability whereGaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
https://reachmd.com/programs/neurofrontiers/gaps-in-schizophrenia-spectrum-disorders-care-a-look-at-causes-and-solutions/32744/Tune in to hear Dr. Natalie Bareis explore gaps in schizophrenia spectrum disorders treatment and how we can expand access to effective care.Diagnosing Muscle Disorders: When to Use Biopsy
https://reachmd.com/programs/neurofrontiers/diagnosing-muscle-disorders-when-to-use-biopsy/26391/Here’s when we should conduct muscle biopsy versus genetic and serological testing to diagnose muscle disorders.The Expanding Role of Peripheral Nerve Stimulation in Acute Pain Control
https://reachmd.com/programs/clinicians-roundtable/the-expanding-role-of-peripheral-nerve-stimulation-in-acute-pain-control/26728/Tune in to learn more about the role of peripheral nerve stimulation in acute pain management.Promising results for self-expanding TAVR device in trial with mostly women
https://reachmd.com/programs/acc-action-center/promising-results-for-self-expanding-tavr-device-in-trial-with-mostly-women/24336/ACC.24 - Hadley Wilson discusses the results of the SMART trial in which 87% were women. In SMART, self-expanding versus balloon-expandable TAVR were compared in patients with a small aortic annulus, most of whom are women.The Gene Messenger: Advancing Neurological Gene Therapy
https://reachmd.com/programs/medical-industry-feature/the-gene-messenger-advancing-neurological-gene-therapy/18094/Hear about groundbreaking advances in neurological gene therapy for patients with Parkinson’s disease.Prurigo Nodularis: Recent Advancements in Addressing Unmet Needs
https://reachmd.com/programs/dermconsult/prurigo-nodularis-recent-advancements-in-addressing-unmet-needs/17996/Dive in to learn about the recent advancements in this field that have brought forth promising data and treatments.Guselkumab Shows Significant Clearance of Scalp Psoriasis in People of Color
https://reachmd.com/programs/dermconsult/guselkumab-shows-significant-clearance-of-scalp-psoriasis-in-people-of-color/17994/Scalp psoriasis remains a challenging dermatological condition to manage, especially in people of color. Read more on the positive results of guselkumab.